1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Volumetric data of control participants and patients with temporal lobe epilepsy
Structures Subjects Control Participants Right TLE Left TLE Hippocampus Mean R volume 3011 (408) 2101 (506)* 3078 (501) Mean L volume 2857 (409) 2943 (510) 2238 (729)* R/L volume ratio 1.06 (0.05)‡ 0.73 (0.22)‡ 1.47 (0.38)‡ Amygdala Mean R volume 1608 (167) 1533 (248) 1667 (237) Mean L volume 1497 (186) 1610 (185) 1440 (400) R/L volume ratio 1.08 (0.06)‡ 0.95 (0.16)‡ 1.24 (0.41)‡ Thalamus Mean R volume 6360 (445) 5217 (797)* 5811 (1056)‡ Mean L volume 6484 (575) 5716 (862)* 5361 (884)† R/L volume ratio 0.98 (0.07) 0.91 (0.09)‡ 1.09 (0.11)‡ Caudate head Mean R volume 3263 (445) 3236 (362) 3248 (440) Mean L volume 3297 (394) 3382 (449) 3271 (514) R/L volume ratio 0.99 (0.06) 0.96 (0.05) 0.99 (0.06) Cerebellar hemispheres Mean R volume 71451 (8589) 66890 (9465) 66756 (8907) Mean L volume 72210 (8347) 68093 (9164) 68134 (9258) R/L volume ratio 0.99 (0.03) 0.98 (0.03) 0.99 (0.03)
Note:—Volumes expressed as mm3, ( ) indicate standard deviations, R indicates right; L, left; R/L, right divided by left; TLE, temporal lobe epilepsy/resection.
* Statistically significant difference between the patient groups and control subjects (p < .0001).
† Statistically significant difference between one patient group and control subjects (p < .02).
‡ Statistically significant difference between 2 or 3 groups (p < .05).